+499.5%
MRNA vs CNQ
+65.4%
+434.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CNQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.3% | -0.9% | -2.6% |
| 7D | +5.5% | +3.0% | +2.5% | +6.3% |
| 30D | +158.7% | +12.8% | +146.0% | +164.7% |
| 3M | +182.1% | +7.0% | +175.1% | +192.5% |
| 6M | +151.8% | +16.5% | +135.3% | +156.9% |
| YTD | +393.6% | +52.0% | +341.5% | +381.1% |
| 1Y | +499.5% | +64.1% | +435.4% | +488.0% |
| All | +499.5% | +65.4% | +434.0% | +488.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CNQ.
Daily Out/Under-Performance
Portfolio return minus CNQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CNQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CNQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling